Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine
Mar 21, 2022
―
Ub-612
Covid-19
Phase I
Completed
A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Jul 12, 2021
―
Ub-612
Covid-19
Phase II
Terminated
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers
Feb 23, 2021
―
Ub-612
Covid-19, Coronavirus, Sars-Cov-2
Phase II/III
Withdrawn
A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine
Dec 10, 2020
―
Ub-612
Covid-19
Phase I
Completed
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Sep 02, 2020
―
Ub-312
Parkinson's Disease, Parkinsonism
Phase I
Completed
Study of UB-312 in Healthy Participants and Parkinson's Disease Patients
Aug 05, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vaxxinity Inc (VAXX) have in its pipeline
VAXX is currently developing the following drugs: Vxx-401, Ub-313, Ub-612, Bnt162b2 Vaccine, Chadox1-S Vaccine, Sinopharm Bibp. These drug candidates are in various stages of clinical development as the company works toward FDA approval.